Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review

Scholarly Works

• Kim, S.; Jo, H.; Lee, S.; Yang, M.; Jun, H.; Lee, Y.; Kim, G.-W.; Lee, D. Targeted echogenic and anti-inflammatory polymeric prodrug nanoparticles for the management of renal ischemia/reperfusion injury. Journal of controlled release : official journal of the Controlled Release Society 2023, 363, 574–584. doi:10.1016/j.jconrel.2023.10.004
• Pan, Y.; Tang, S.; Zhu, L.; Lou, D.; Tan, J.; Wang, B. Design of St-2-2 7α-HSDH mutants for altering substrate preference and thermostability. Molecular Catalysis 2023, 548, 113423. doi:10.1016/j.mcat.2023.113423
• Kim, O. Y.; Lee, S. Y.; Lee, D. Y.; Hur, S. J. Developing a procedure to extract chenodeoxycholic acid and synthesize ursodeoxycholic acid from pig by-products. Heliyon 2023, 9, e18313. doi:10.1016/j.heliyon.2023.e18313
• Liu, T.; Wang, J.-S. Ursodeoxycholic acid administration did not reduce susceptibility to SARS-CoV-2 infection in children. Liver international : official journal of the International Association for the Study of the Liver 2023, 43, 1950–1954. doi:10.1111/liv.15660
• d'Oelsnitz, S.; Stofel, S. K.; Ellington, A. D. Snowprint: a predictive tool for genetic biosensor discovery. Cold Spring Harbor Laboratory 2023. doi:10.1101/2023.04.29.538814
• Huang, Y.; Lu, H.; Li, Z.; Zeng, Y.; Xu, Q.; Wu, Y. Development of HPLC-CAD method for simultaneous quantification of nine related substances in ursodeoxycholic acid and identification of two unknown impurities by HPLC-Q-TOF-MS. Journal of pharmaceutical and biomedical analysis 2023, 229, 115357. doi:10.1016/j.jpba.2023.115357
• Yu, L.; Liu, Y.; Wang, S.; Zhang, Q.; Zhao, J.; Zhang, H.; Narbad, A.; Tian, F.; Zhai, Q.; Chen, W. Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies. Gut microbes 2023, 15, 2181930. doi:10.1080/19490976.2023.2181930
• Song, P.; Zhang, X.; Feng, W.; Xu, W.; Wu, C.; Xie, S.; Yu, S.; Fu, R. Biological synthesis of ursodeoxycholic acid. Frontiers in microbiology 2023, 14, 1140662. doi:10.3389/fmicb.2023.1140662
• Yang, B.-Y.; You, Z.-N.; Xue, J.-T.; Pan, J.; Li, C.-X.; Xu, J.-H. Clean enzymatic production of ursodeoxycholic acid enabled by a newly identified NADH-dependent 7β-hydroxysteroid dehydrogenase. Molecular Catalysis 2023, 537, 112946. doi:10.1016/j.mcat.2023.112946
• Huang, B.; Yang, K.; Amanze, C.; Yan, Z.; Zhou, H.; Liu, X.; Qiu, G.; Zeng, W. Sequence and structure-guided discovery of a novel NADH-dependent 7β-hydroxysteroid dehydrogenase for efficient biosynthesis of ursodeoxycholic acid. Bioorganic chemistry 2022, 131, 106340. doi:10.1016/j.bioorg.2022.106340
• Li, H.-P.; Yang, B.-Y.; Su, Y.; You, Z.-N.; Yin, W.-T.; Li, C.-X.; Zheng, G.-W.; Qu, J.; Xu, J.-H. Sustainable and Robust Closed-Loop Enzymatic Platform for Continuous/Semi-continuous Synthesis of Ursodeoxycholic Acid. ACS Sustainable Chemistry & Engineering 2022, 10, 16916–16923. doi:10.1021/acssuschemeng.2c05741
• Benedetto Tiz, D.; Bagnoli, L.; Rosati, O.; Marini, F.; Santi, C.; Sancineto, L. FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis. Pharmaceutics 2022, 14, 2538. doi:10.3390/pharmaceutics14112538
• Favale, N.; Costa, S.; Scapoli, C.; Carrieri, A.; Sabbioni, S.; Tamburini, E.; Benazzo, A.; Bernacchia, G. Reconstruction of Acinetobacter johnsonii ICE_NC genome using hybrid de novo genome assemblies and identification of the 12α-hydroxysteroid dehydrogenase gene. Journal of applied microbiology 2022, 133, 1506–1519. doi:10.1111/jam.15657
• Liu, Z.; Zhang, R.; Zhang, W.; Xu, Y. Effects of terminal modification on the catalytic efficiency and thermostability of Brucella melitensis 7α-hydroxysteroid dehydrogenase. Systems Microbiology and Biomanufacturing 2022, 3, 469–478. doi:10.1007/s43393-022-00124-5
• Kollerov, V.; Donova, M. Ursodeoxycholic acid production by Gibberella zeae mutants. AMB Express 2022, 12, 105. doi:10.1186/s13568-022-01446-2
• Pan, Y.; Tang, S.; Zhou, M.; Ao, F.; Tang, Z.; Zhu, L.; Lou, D.; Tan, J.; Wang, B. A Novel NADP(H)-Dependent 7alpha-HSDH: Discovery and Construction of Substrate Selectivity Mutant by C-Terminal Truncation. Catalysts 2022, 12, 781. doi:10.3390/catal12070781
• Reich, J. A.; Aßmann, M.; Hölting, K.; Bubenheim, P.; Kuballa, J.; Liese, A. Shift of the reaction equilibrium at high pressure in the continuous synthesis of neuraminic acid. Beilstein journal of organic chemistry 2022, 18, 567–579. doi:10.3762/bjoc.18.59
• Zhao, Y.-Q.; Liu, Y.-J.; Ji, W.-T.; Liu, K.; Gao, B.; Tao, X.-Y.; Zhao, M.; Wang, F.-Q.; Wei, D.-Z. One-pot biosynthesis of 7β-hydroxyandrost-4-ene-3,17-dione from phytosterols by cofactor regeneration system in engineered mycolicibacterium neoaurum. Microbial cell factories 2022, 21, 59. doi:10.1186/s12934-022-01786-5
• Jin, L.; Yang, L.; Zhao, S.; Wang, Z. A green strategy to produce potential substitute resource for bear bile using engineered Saccharomyces cerevisiae. Bioresources and Bioprocessing 2022, 9. doi:10.1186/s40643-022-00517-3
• Shi, M.; Tang, J.; Zhang, T.; Han, H. Swertiamarin, an active iridoid glycoside from Swertia pseudochinensis H. Hara, protects against alpha-naphthylisothiocyanate-induced cholestasis by activating the farnesoid X receptor and bile acid excretion pathway. Journal of ethnopharmacology 2022, 291, 115164. doi:10.1016/j.jep.2022.115164

Explore citations to this article at